KDM6A loss triggers an epigenetic switch that disrupts urothelial differentiation and drives cell proliferation in bladder cancer Journal Article


Authors: Qiu, H.; Makarov, V.; Bolzenius, J. K.; Halstead, A.; Parker, Y.; Wang, A.; Iyer, G. V.; Wise, H.; Kim, D.; Thayaparan, V.; Lindner, D. J.; Haber, G. P.; Ting, A. H.; Ren, B.; Chan, T. A.; Arora, V.; Solit, D. B.; Lee, B. H.
Article Title: KDM6A loss triggers an epigenetic switch that disrupts urothelial differentiation and drives cell proliferation in bladder cancer
Abstract: Disruption of KDM6A, a histone lysine demethylase, is one of the most common somatic alternations in bladder cancer. Insights into how KDM6A mutations affect the epigenetic landscape to promote carcinogenesis could help reveal potential new treatment approaches. Here, we demonstrated that KDM6A loss triggers an epigenetic switch that disrupts urothelial differentiation and induces a neoplastic state characterized by increased cell proliferation. In bladder cancer cells with intact KDM6A, FOXA1 interacted with KDM6A to activate genes instructing urothelial differentiation. KDM6A-deficient cells displayed simultaneous loss of FOXA1 target binding and genome-wide redistribution of the bZIP transcription factor ATF3, which in turn repressed FOXA1-target genes and activated cell-cycle progression genes. Importantly, ATF3 depletion reversed the cell proliferation phenotype induced by KDM6A deficiency. These data establish that KDM6A loss engenders an epigenetic state that drives tumor growth in an ATF3-dependent manner, creating a potentially targetable molecular vulnerability. SIGNIFICANCE: A gain-of-function epigenetic switch that disrupts differentiation is triggered by inactivating KDM6A mutations in bladder cancer and can serve as a potential target for novel therapies. ©2023 The Authors; Published by the American Association for Cancer Research.
Keywords: genetics; cell proliferation; metabolism; cell differentiation; pathology; bladder tumor; urinary bladder neoplasms; epigenesis, genetic; genetic epigenesis; histone demethylase; histone demethylases; humans; human; kdm6a protein, human
Journal Title: Cancer Research
Volume: 83
Issue: 6
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2023-03-15
Start Page: 814
End Page: 829
Language: English
DOI: 10.1158/0008-5472.Can-22-1444
PUBMED: 36638328
PROVIDER: scopus
PMCID: PMC10015223
DOI/URL:
Notes: Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. David Solit
    780 Solit
  2. Gopakumar Vasudeva Iyer
    348 Iyer
  3. Hannah Christina Wise
    12 Johnsen